Insta

US Stops Production Of AstraZeneca's COVID-19 Vaccines At A Baltimore-Based Vaccine Maker's Facility

Swarajya StaffApr 05, 2021, 11:06 AM | Updated 11:06 AM IST
 AstraZeneca 

AstraZeneca 


In a major development, the United States (US)' Health and Human Services Department has stopped a Baltimore, Maryland-based vaccine manufacturer from producing doses of AstraZeneca's COVID-19 vaccines, reports Livemint.

The development comes days after Emergent BioSolutions had ruined a whopping 15 million doses of the COVID-19 vaccine developed by Johnson & Johnson (J&J) as it accidentally mixed up ingredients from two different vaccines. The mix-up forced the regulator to step in and delay the approval of the output from the facility.


It should be noted that AstraZeneca's COVID-19 vaccine has been developed in collaboration with the University of Oxford. The same is being manufactured in India by Pune based Serum Institute of India (SII) under the name 'Covishield'.

Join our WhatsApp channel - no spam, only sharp analysis